Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Intelligence Hub
News
Changes
Search
Log in
Get Started
CYPSEDO (CIPEPOFOL) | LOERadar
Viewing data from:
Latest
2026-10-01
2026-09-01
2026-08-03
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
CYPSEDO
NDA
CIPEPOFOL | N220482 | HAISCO-USA PHARMACEUTICALS INC
1 strength
2 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
2 unique patents, 1 exclusivity by expiration date
Active (2)
Today
Exclusivity
2027
2028
2029
2030
2031
2032
2033
2034
Today
9517988
May. 6, 2034
10729666
May. 6, 2034
NCE
Aug. 27, 2031
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 50MG/20ML (2.5MG/ML)
RLD
2 patents
1 exclusivity
▴
EMULSION;INTRAVENOUS | Approved: Aug 27, 2026
Patents (2)
· 2 use codes
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9517988
Newly listed — daily FDA feed, not yet in monthly Orange Book edition
May 6, 2034
—
Yes
—
U-4599
INDUCING GENERAL ANESTHESIA IN ADULTS UNDERGOING SURGERY
—
10729666
Newly listed — daily FDA feed, not yet in monthly Orange Book edition
May 6, 2034
—
—
Yes
U-4599
INDUCING GENERAL ANESTHESIA IN ADULTS UNDERGOING SURGERY
—
Exclusivities (1)
Code
Date
Status
NCE
Aug 27, 2031
Active